Hi Mozza, i am usually able to follow your analysis quite easily, but i don't follow your response to @MixedBag or his comments before. You 2 are on a higher level. Can you expand on whether you think PAR are changing course somewhat in the upcoming trials and why, please?
BTW it seems that either a deal or a CR is unavoidable. IMO. DYOR. I have pointed out to Simon White that another company has obtained funding at 3.5% (yep 3.5%) discount for their non-revenue earning company's R&D*, and suggested that PAR look to other than Bell Potter next time. Maybe some of you should raise your concerns about a CR through whom, with Simon..
*I don't want to promote it here, but they were in a trading halt until today, and I hold them. My point is there are other ways to raise capital than PAR have been using.
PAR Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)